← Eichor
Condition: Urethral Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Urethral Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT0589936124 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
NA · 1 location(s) · IRCCS San Raffaele · NCT05936736Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment
Phase N/A · 1 location(s) · Fundación Instituto Valenciano de Oncología · NCT02901392A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT0721717164Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/Phase 2 · 1 location(s) · Rahul Aggarwal · NCT05888532MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT05438563DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours
Phase 4 · 1 location(s) · University of Roma La Sapienza · NCT05962541Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
NA · 8 location(s) · Varian, a Siemens Healthineers Company · NCT05804318Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT
NA · 1 location(s) · Fundacao Champalimaud · NCT04035642Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · 499 location(s) · National Cancer Institute (NCI) · NCT05987241MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
Phase N/A · 1 location(s) · Jiangsu Taizhou People's Hospital · NCT07694752A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
NA · 1 location(s) · Suzhou Municipal Hospital · NCT06754488Retzius-sparing Robot-assisted Radical Prostatectomy With "Sandwich" Technique of Total Urethral Reconstruction Versus S
NA · 1 location(s) · Ministry of Science and Technology of the People´s Republic · NCT06730243Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Phase 2 · 1 location(s) · Nagoya University · NCT06983210Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer
NA · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT05832736Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Photon-Counting Computed Tomography-Based Urethral Visualization Without Catheterization for Radiotherapy Planning: A Pr
Phase N/A · 1 location(s) · Istituto Clinico Humanitas · NCT07730203Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Comparing Rezum and Urolift
NA · 1 location(s) · Chinese University of Hong Kong · NCT06820606Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
NA · 2 location(s) · Sami-Ramzi Leyh-Bannurah · NCT07678489
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.